HR 8339 · 119th Congress

Drug Origin Transparency Act of 2026

The Drug Origin Transparency Act of 2026 requires pharmaceutical companies to provide much more detailed information about where their drugs come from and who makes them. Right now, drug manufacturers report basic information about their products once a year. This bill changes that by requiring them to report more f…

Sponsor

Matsui, Doris O. (D-California)

Introduced

2026-04-16

Policy area

Health